Christian W Mandl

Author PubWeight™ 38.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A 2012 2.59
2 Vaccines for the twenty-first century society. Nat Rev Immunol 2011 2.34
3 Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Natl Acad Sci U S A 2011 2.08
4 Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol 2003 1.90
5 Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J Virol 2002 1.48
6 Functional microRNA generated from a cytoplasmic RNA virus. Nucleic Acids Res 2010 1.30
7 Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J Virol 2003 1.28
8 Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J Virol 2006 1.28
9 Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc Natl Acad Sci U S A 2004 1.23
10 Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus. J Virol 2003 1.17
11 Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C. J Virol 2003 1.15
12 RNA-based vaccines. Vaccine 2012 1.08
13 Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 2003 1.06
14 A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination. J Virol 2010 1.05
15 Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus. J Virol 2005 1.02
16 Construction and mutagenesis of an artificial bicistronic tick-borne encephalitis virus genome reveals an essential function of the second transmembrane region of protein e in flavivirus assembly. J Virol 2006 1.01
17 RNA: the new revolution in nucleic acid vaccines. Semin Immunol 2013 0.99
18 Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles. J Virol 2004 0.97
19 Analysis of the effects of alterations in the tick-borne encephalitis virus 3'-noncoding region on translation and RNA replication using reporter replicons. Virology 2008 0.95
20 Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virol J 2010 0.93
21 Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. Vaccine 2012 0.93
22 Extension of flavivirus protein C differentially affects early RNA synthesis and growth in mammalian and arthropod host cells. J Virol 2009 0.91
23 Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virions. J Virol 2009 0.91
24 Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus. J Virol 2005 0.90
25 Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. J Gen Virol 2005 0.89
26 Functional analysis of potential carboxy-terminal cleavage sites of tick-borne encephalitis virus capsid protein. J Virol 2007 0.85
27 Generation of a parvovirus B19 vaccine candidate. Vaccine 2013 0.82
28 Selection and analysis of mutations in an encephalomyocarditis virus internal ribosome entry site that improve the efficiency of a bicistronic flavivirus construct. J Virol 2007 0.82
29 Mutational analysis of three predicted 5'-proximal stem-loop structures in the genome of tick-borne encephalitis virus indicates different roles in RNA replication and translation. Virology 2011 0.80
30 Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations. Vaccine 2010 0.79
31 Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus. J Virol 2008 0.78
32 Antibody affinity maturation and respiratory syncytial virus disease. Nat Med 2009 0.77
33 Influenza vaccination: policy versus evidence: protection from disease versus disease severity. BMJ 2006 0.75
34 The interface of animal and human vaccines. Curr Opin Virol 2012 0.75